UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 2,737,728 Shares of Schrodinger, Inc. $SDGR

Key Points

• UBS Asset Management significantly increased its stake in Schrodinger, Inc. by 169.0%, acquiring an additional 2,737,728 shares, bringing its total ownership to approximately 5.97% of the company, valued at $86 million.
• Analysts have varying ratings for Schrodinger, with KeyCorp setting a target price of $30, while Citigroup reduced theirs from $35 to $20, reflecting a shift to a neutral rating.
• Schrodinger's latest quarterly earnings report revealed a revenue increase of 15.7% year-over-year, with an earnings per share of ($0.59) that beat analyst expectations.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 169.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,357,532 shares of the company's stock after purchasing an additional 2,737,728 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 5.97% of Schrodinger worth $86,018,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Two Sigma Advisers LP bought a new stake in shares of Schrodinger in the 4th quarter worth approximately $473,000. Allspring Global Investments Holdings LLC boosted its stake in Schrodinger by 30.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 174,371 shares of the company's stock worth $3,442,000 after buying an additional 40,568 shares in the last quarter. GAMMA Investing LLC increased its holdings in Schrodinger by 118.5% in the 1st quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after buying an additional 3,313 shares during the period. BNP Paribas Financial Markets acquired a new position in shares of Schrodinger in the 4th quarter valued at $330,000. Finally, Two Sigma Investments LP acquired a new stake in shares of Schrodinger during the 4th quarter valued at about $1,939,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on SDGR shares. KeyCorp lowered their target price on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Citigroup cut shares of Schrodinger from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $35.00 to $20.00 in a research note on Friday, August 15th. Wall Street Zen lowered shares of Schrodinger from a "hold" rating to a "sell" rating in a report on Saturday, August 30th. Barclays started coverage on Schrodinger in a report on Thursday, August 14th. They issued an "overweight" rating and a $25.00 target price on the stock. Finally, Morgan Stanley dropped their price target on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating for the company in a report on Monday, August 18th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Schrodinger presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.83.

Schrodinger Trading Down 1.1%

Schrodinger stock opened at $18.57 on Friday. The company has a market cap of $1.37 billion, a PE ratio of -7.49 and a beta of 1.79. Schrodinger, Inc. has a 1 year low of $16.60 and a 1 year high of $28.47. The company's 50-day moving average is $20.22 and its two-hundred day moving average is $21.62.

Schrodinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, topping analysts' consensus estimates of ($0.83) by $0.24. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. The business had revenue of $54.76 million during the quarter, compared to the consensus estimate of $52.03 million. During the same period in the previous year, the firm posted ($0.66) earnings per share. Schrodinger's revenue for the quarter was up 15.7% compared to the same quarter last year. Research analysts forecast that Schrodinger, Inc. will post -2.37 EPS for the current year.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrodinger, Inc. (NASDAQ:SDGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.